Related Experiment Videos
[The prevention and treatment for restenosis in coronary angioplasty]
1Division of Cardiology, Tokyo Seamen's Insurance Hospital.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) is widely used for ischemic heart disease. While coronary stents improve outcomes by preventing vessel shrinking, their widespread use may negate benefits.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Context:
- Percutaneous transluminal coronary angioplasty (PTCA) is a standard treatment for ischemic heart disease (IHD).
- Restenosis within six months post-PTCA remains a significant clinical challenge.
- Pharmacological treatments have largely failed to reduce restenosis rates.
Purpose:
- To review the efficacy of coronary stents in preventing restenosis after PTCA.
- To discuss the role of vessel remodeling in restenosis.
- To evaluate the impact of increasing stent implantation rates on PTCA outcomes.
Summary:
- Coronary stents, such as the Palmaz-Schatz stent, have shown promise in reducing restenosis after PTCA.
- Intravascular ultrasound (IVUS) studies indicate that vessel remodeling (shrinking) is a primary driver of restenosis.
- Stents prevent vessel shrinking, thereby improving restenosis rates, but increased implantation may offset this benefit.
Impact:
- Coronary stenting has improved PTCA outcomes by mitigating restenosis.
- Understanding vessel remodeling is crucial for optimizing PTCA and stenting strategies.
- The expanding use of stents necessitates careful consideration of patient selection and procedural techniques to maintain efficacy.
Abstract:
Since the invention of Gruentzig AR in 1977, percutaneous transluminal coronary angioplasty (PTCA) has become a widely accepted therapeutic modality for the treatment of patients with ischemic heart disease (IHD). Restenosis which occurs within six months is a major problem of PTCA. Several clinical trials of pharmacological regimen have failed to show significant improvements in restenosis. Palmaz-Schatz stent could improve in restenosis. STRESS and BENESTENT DCA also could improve in restenosis when aggressive debulking was succeeded (BOAT and OARS). The recent IVUS studies have demonstrated that vessel remodeling (vessel shrinking) was the major factor of restenosis. Stent contributes to the prevention of the vessel shrinking, which leads to the improvement in restenosis. However, the rapid increase in stent implantation rates with widening indications cancels the beneficial effect of stent.